​
​

Dianthus Therapeutics (MGTA) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Dianthus Therapeutics Revenue Highlights

Latest Revenue (Y)

$314.00K

Latest Revenue (Q)

$72.00K

Dianthus Therapeutics Revenue by Period

Dianthus Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$314.00K-82.28%
2022-12-31$1.77M-40.20%
2021-12-31$2.96M182.19%
2020-12-31$1.05M-76.46%
2019-12-31$4.46M-46.80%
2018-12-31$8.39M109.49%
2017-12-31$4.00M19.96%
2016-12-31$3.34M31.48%
2015-12-31$2.54M-41.25%
2014-12-31$4.32M0.08%
2013-12-31$4.32M-2.03%
2012-12-31$4.41M-

Dianthus Therapeutics generated $314.00K in revenue during NA 2023, up -82.28% compared to the previous quarter, and up 3.74% compared to the same period a year ago.

Dianthus Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31$72.00K-
2023-12-31$72.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--100.00%
2016-12-31$756.00K-

Dianthus Therapeutics generated $72.00K in revenue during Q1 2024, up 0.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Dianthus Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$101.21M$33.43M
SPROSpero Therapeutics$96.73M$13.47M
ASMBAssembly Biosciences$7.16M$6.84M
MGTADianthus Therapeutics$314.00K$72.00K
NXTCNextCure--
TILInstil Bio--
NLTXNeurogene--
ACHLAchilles Therapeutics--
NUVBNuvation Bio-$727.00K

MGTA Revenue FAQ

What is Dianthus Therapeutics’s yearly revenue?

Dianthus Therapeutics's yearly revenue for 2023 was $314K, representing a decrease of -82.28% compared to 2022. The company's yearly revenue for 2022 was $1.77M, representing a decrease of -40.20% compared to 2021. MGTA's yearly revenue for 2021 was $2.96M, representing an increase of 182.19% compared to 2020.

What is Dianthus Therapeutics’s quarterly revenue?

Dianthus Therapeutics's quarterly revenue for Q1 2024 was $72K, a 0% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $72K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). MGTA's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

What is Dianthus Therapeutics’s revenue growth rate?

Dianthus Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -89.40%, and for the last 5 years (2019-2023) was -92.96%.